Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis
- 8 December 2005
- journal article
- Published by Springer Nature in Leukemia
- Vol. 20 (2) , 350-353
- https://doi.org/10.1038/sj.leu.2404069
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersBlood, 2005
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisPublished by Elsevier ,2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersThe Lancet, 2005
- A Polycythemia Vera Update: Diagnosis, Pathobiology, and TreatmentHematology-American Society Hematology Education Program, 2000
- A Polycythemia Vera Update: Diagnosis, Pathobiology, and TreatmentHematology-American Society Hematology Education Program, 2000